• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克利夫兰诊所卢沃大脑健康中心:保持记忆鲜活。

The Cleveland Clinic Lou Ruvo Center for Brain Health: keeping memory alive.

机构信息

Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA.

出版信息

J Alzheimers Dis. 2014;38(1):103-9. doi: 10.3233/JAD-130791.

DOI:10.3233/JAD-130791
PMID:23948939
Abstract

The Cleveland Clinic Lou Ruvo Center for Brain Health (LRCBH) is a unique clinical and translational research enterprise that stems from the passion of Larry Ruvo to honor his father, Lou, a victim of Alzheimer's disease (AD). To attract national attention to AD, Mr. Ruvo convinced architect Frank Gehry to construct the remarkable building complex of the LRCBH in Las Vegas, Nevada. Cleveland Clinic assumed responsibility for running the clinical and research aspects of the LRCBH. The care provided in this novel architectural setting is innovative and emphasizes patients first care with integration of caregiver programs and clinical research opportunities. Standardization of care, outcomes measures, and process metrics provide a platform for assessing, studying, and exporting best practices in cognitive care. Clinical trials empower patients to help solve the diseases that afflict them. The combination of a passionate founder, dramatic architecture, clinical excellence, integrated care partner programs, and commitment to development of next generation treatments makes the LRCBH a unique model of integrated care and research.

摘要

克利夫兰诊所卢鲁沃脑健康中心(LRCBH)是一个独特的临床和转化研究机构,源于拉里·鲁沃(Larry Ruvo)的热情,旨在纪念他的父亲——路易(Lou),一位阿尔茨海默病(AD)患者。为了引起全国对 AD 的关注,鲁沃先生说服建筑师弗兰克·盖里(Frank Gehry)在内华达州拉斯维加斯建造了这座令人瞩目的 LRCBH 建筑群。克利夫兰诊所负责管理 LRCBH 的临床和研究方面。在这种新颖的建筑环境中提供的护理具有创新性,并强调患者的首要护理,整合护理人员计划和临床研究机会。护理的标准化、结果测量和流程指标为评估、研究和输出认知护理的最佳实践提供了一个平台。临床试验使患者能够帮助解决困扰他们的疾病。充满激情的创始人、戏剧性的建筑、卓越的临床水平、综合护理合作伙伴计划以及对下一代治疗方法的开发承诺,使 LRCBH 成为一个独特的综合护理和研究模式。

相似文献

1
The Cleveland Clinic Lou Ruvo Center for Brain Health: keeping memory alive.克利夫兰诊所卢沃大脑健康中心:保持记忆鲜活。
J Alzheimers Dis. 2014;38(1):103-9. doi: 10.3233/JAD-130791.
2
Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Centers of excellence in Alzheimer's disease: it is time to better integrate patient care and clinical research to improve the prevention and treatment of Alzheimer's disease.关于《预防痴呆症路线图II. 2008年莱昂·索尔研讨会》的评论。阿尔茨海默病卓越中心:是时候更好地整合患者护理与临床研究,以改善阿尔茨海默病的预防和治疗了。
Alzheimers Dement. 2009 Mar;5(2):133-6. doi: 10.1016/j.jalz.2009.01.006.
3
Design of comprehensive Alzheimer's disease centers to address unmet national needs.设计综合性阿尔茨海默病中心,以满足未满足的国家需求。
Alzheimers Dement. 2010 Mar;6(2):150-5. doi: 10.1016/j.jalz.2009.11.004.
4
The Toulouse Gérontopôle Research Center: report of activities, 2007-2011.《图卢兹老年医学研究中心活动报告,2007-2011》。
J Alzheimers Dis. 2012;28(3):721-32. doi: 10.3233/JAD-2011-112202.
5
[Excellence and creativity: the story of Sheba Medical Center].卓越与创新:舍巴医疗中心的故事
Harefuah. 2015 Feb;154(2):127-8.
6
Institutional profile: integrated center for research and treatment of vertigo, balance and ocular motor disorders.机构简介:眩晕、平衡和眼动障碍的研究与治疗综合中心。
Restor Neurol Neurosci. 2010;28(1):135-43. doi: 10.3233/RNN-2010-0510.
7
Creating a transatlantic research enterprise for preventing Alzheimer's disease.创建一个跨大西洋的预防阿尔茨海默病研究机构。
Alzheimers Dement. 2009 Jul;5(4):361-6. doi: 10.1016/j.jalz.2009.05.158.
8
The schism between medical and public health education: a historical perspective.医学教育与公共卫生教育之间的分歧:历史视角
Acad Med. 2008 Dec;83(12):1153-7. doi: 10.1097/ACM.0b013e31818c6583.
9
Bengt Winblad: coaching the team in Alzheimer's disease.本特·温布拉德:指导阿尔茨海默病研究团队。
Lancet Neurol. 2009 Jun;8(6):514. doi: 10.1016/S1474-4422(09)70119-X.
10
The future of Alzheimer's disease: the next 10 years.阿尔茨海默病的未来:未来 10 年。
Prog Neurobiol. 2011 Dec;95(4):718-28. doi: 10.1016/j.pneurobio.2011.11.008. Epub 2011 Nov 22.

引用本文的文献

1
Thermodynamic and kinetic design principles for amyloid-aggregation inhibitors.淀粉样蛋白聚集抑制剂的热力学和动力学设计原则。
Proc Natl Acad Sci U S A. 2020 Sep 29;117(39):24251-24257. doi: 10.1073/pnas.2006684117. Epub 2020 Sep 14.
2
Neuroscience learning from longitudinal cohort studies of Alzheimer's disease: Lessons for disease-modifying drug programs and an introduction to the Center for Neurodegeneration and Translational Neuroscience.从阿尔茨海默病纵向队列研究中学习神经科学:对疾病修饰药物项目的启示以及神经退行性变与转化神经科学中心简介
Alzheimers Dement (N Y). 2018 Jul 11;4:350-356. doi: 10.1016/j.trci.2018.06.006. eCollection 2018.
3
The price of progress: Funding and financing Alzheimer's disease drug development.
进步的代价:阿尔茨海默病药物研发的资金与融资
Alzheimers Dement (N Y). 2018 Jun 13;4:330-343. doi: 10.1016/j.trci.2018.04.008. eCollection 2018.
4
Neurodegeneration research: Advances in clinical translational neuroscience infrastructure and methods.神经退行性变研究:临床转化神经科学基础设施与方法的进展
Alzheimers Dement (N Y). 2018 Jun 1;4:326-329. doi: 10.1016/j.trci.2018.03.008. eCollection 2018.